Evidence map›Paper›PMID 33519679›Full record

ArticleFrontiers in neurology2020

Early-Onset Parkinson Disease Screening in Patients From Nigeria.

Lukasz M Milanowski, Olajumoke Oshinaike, Benjamin J Broadway, Jennifer A Lindemann, Alexandra I Soto-Beasley, Ronald L Walton, Rana Hanna Al-Shaikh, Audrey J Strongosky, Fabienne C Fiesel, Owen A Ross and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Genetic Landscape of Monogenic Parkinson's Disease in the African Population-A Systematic Review.Movement disorders : official journal of the Movement Disorder Society · 2026
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Copy Number Variation in Parkinson's Disease: An Update from Sub-Saharan Africa.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Lukasz M MilanowskiDepartment of Neurology, Mayo Clinic Florida, Jacksonville, FL, United States.
Olajumoke OshinaikeDepartment of Neurology, Lagos State University Teaching Hospital, Lagos, Nigeria.
Benjamin J BroadwayDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Jennifer A LindemannDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Alexandra I Soto-BeasleyDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Ronald L WaltonDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Rana Hanna Al-ShaikhDepartment of Neurology, Mayo Clinic Florida, Jacksonville, FL, United States.
Audrey J StrongoskyDepartment of Neurology, Mayo Clinic Florida, Jacksonville, FL, United States.
Fabienne C FieselDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Owen A RossDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Wolfdieter SpringerDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, United States.
Shamsideen Abayomi OgunDepartment of Neurology, Lagos State University Teaching Hospital, Lagos, Nigeria.
Zbigniew K WszolekDepartment of Neurology, Mayo Clinic Florida, Jacksonville, FL, United States.
Mayo Clinic in Florida · USJacksonville College · USLagos State University Teaching Hospital · NG

Funding

Utilization of proteomics and lipidomics to identify modifiers of LBDU54NS110435 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM, MCLEAN, PAMELA J · 2019 to 2023
$14.5M
Project 2: Identifying genes and Pathways that impact Tau Toxicity in FTDU54NS100693 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 2016 to 2020
$6.2M
Molecular mechanisms of PINK1-PRKN directed mitochondrial quality controlRF1NS085070 · NINDS · MAYO CLINIC JACKSONVILLE · PI SPRINGER, WOLFDIETER · 2019 to 2019
$2.8M
Mitochondrial Sirtuin 3 in Parkinson's diseaseR01NS110085 · NINDS · MAYO CLINIC JACKSONVILLE · PI MCLEAN, PAMELA J, SPRINGER, WOLFDIETER · 2019 to 2023
$2.5M
Understanding the role of MAPT in Parkinsonian disordersR01NS078086 · NINDS · MAYO CLINIC JACKSONVILLE · PI ROSS, OWEN A · 2012 to 2016
$1.7M
Selective autophagy in Alzheimer's disease and related dementiasR56AG062556 · NIA · MAYO CLINIC JACKSONVILLE · PI FRYER, JOHN DAVID, SPRINGER, WOLFDIETER · 2019 to 2019
$782k
NIA NIH HHS R56 AG062556NINDS NIH HHS R01 NS078086NINDS NIH HHS R01 NS110085NINDS NIH HHS RF1 NS085070NINDS NIH HHS U54 NS100693NINDS NIH HHS U54 NS110435
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DJ1LRRK2MLPANigerian populationParkinson diseasePINK1PRKNSanger sequencing

Identifiers

PMID33519679
PMCPMC7841006
OpenAlexW3120494639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.